Anagallis Arvensis
NDC 63545-983, Anagallis Arvernsis, pellet, from Hahnemann Laboratories, Inc..
- Product NDC
- 63545-983
- Status
- Listed
- Labeler
- Hahnemann Laboratories, Inc.
- Dosage form
- PELLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63545-983 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ANAGALLIS ARVENSIS WHOLE200 [hp_C]/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63545-983-01 | 63545098301 | 200 PELLET in 1 VIAL, GLASS (63545-983-01) |
| 63545-983-02 | 63545098302 | 500 PELLET in 1 VIAL (63545-983-02) |
| 63545-983-03 | 63545098303 | 3000 PELLET in 1 BOTTLE, GLASS (63545-983-03) |
| 63545-983-04 | 63545098304 | 10000 PELLET in 1 BOTTLE, GLASS (63545-983-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63545-983 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63545-983 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63545-983. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.